No Detail Found!

Comparison of efficacy and safety of topiramate with gabapentin in migraine prophylaxis: Randomized open label control trial.

Author(s)
Syeda Zain Department of Pharmacology, BMSI, JPMC, Karachi, Pakistan
Moosa Khan Department of Pharmacology, BMSI, JPMC, Karachi, Pakistan
Rafique Alam Department of Pharmacology, University of Karachi, Pakistan
Irfan Zafar Department of Pharmacology, Hamdard University, Karachi, Pakistan
Shakil Ahmed Department of Neurology, JPMC, Karachi, Pakistan
Abstract
Objective: To compare the efficacy and safety of topiramate with gabapentin in the prophylaxis of migraine patients. Methods: A 12-week randomised open label control trial was conducted at the Department of Pharmacology and Therapeutics, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre (JPMC), Karachi from January to March 2011 involving 80 outpatients who had a history of migraine. The sample was divided into two equal groups. Primary efficacy measure was changed into mean monthly migraine frequency. Secondary efficacy measure included reduction in severity and average duration of an attack. Chi square test and paired t-test were used to analyse the data through SPSS 15. Result: Reduction in mean monthly migraine frequency (10.67±4.25 to 1.82±2.02) in the topiramate group was significantly greater compared with (11.97±4.452 to 2.73±2.59) that in the gabapentin group (p
Publication Details
Page(s) 3-7
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 63, Issue: 1, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

80

Views